BMY vs ECPG · P/E 17, rev $48.19B vs P/E 6.3, rev $1.32B
Bristol-Myers Squibb Company (BMY) versus Encore Capital Group Inc (ECPG) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Encore Capital Group Inc (ECPG) is a credit services company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ECPG revenue for 2024-12-31 was $1.32B. Net income was -$139.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
Not investment advice. Open the BMY and ECPG stock pages for the full models.
Not investment advice.